NewBridge Pharmaceuticals Hosts a Conference on Genomic Testing to Bring Hope to Patients with Breast Cancer

Use of OncotypeDX® Changes Treatment Recommendations for Women With Hormone Receptor Positive, Her2 Negative Breast Cancer, Leading to Overall Reduction in Chemotherapy NewBridge Pharmaceuticals, the regional licensed representative for class-leading medical diagnostic solutions, held a press conference highlighting the latest advancements in genomic breast cancer screening methods on Monday, November 17th at Radisson Blu Hotel [...]

Bridging East and West for Biotech

Joe Henein, President & CEO of NewBridge Pharmaceuticals, talks about the evolution of the company since his joining, what makes NewBridge Pharmaceuticals a unique partner within the industry…    

NewBridge Pharmaceuticals Enters into a Partnership with Eisai to Market Breast Cancer Treatment Halaven® (ERIBULIN) in the Middle East region

NEWBRIDGE ANNOUNCES PARTNERSHIP WITH EISAI TO MARKET BREAST CANCER TREATMENT HALAVEN® (ERIBULIN) ACROSS THE MIDDLE EAST  Dubai, UAE, 18 November 2013 – Eisai announces today that Halaven® (eribulin) will be marketed in selected countries within the Middle East region through a new partnership between Eisai EMEA (Europe, the Middle East, Africa, Russia and Oceania) and [...]

NewBridge Pharmaceuticals secures significant investment from Elan, boosting growth and expansion

Elan Corporation, plc. invests Series C financing in NewBridge Pharmaceuticals and becomes a major shareholder alongside Burrill & Company and Kuwait Life Sciences Company. Dubai, UAE: 29 May, 2013: NewBridge Pharmaceuticals  announced the close of a Series C equity fundraising from the Irish corporation, Elan, to expand its commercial and manufacturing operations in the Africa, Middle [...]

NewBridge Pharmaceuticals to Commercialize the verifi™ prenatal test

New Non-Invasive Prenatal Test Now Available to Patients in the Middle East, Turkey, Africa, and Caspian Regions Dubai, UAE: 17 February, 2013 – NewBridge Pharmaceuticals, a specialty therapeutics company commercializing pharmaceuticals, biologics, diagnostics and medical devices across the AfMET region (Middle East, Africa, Turkey & Caspian regions), today announced that the company has established an [...]